Allianz Asset Management Gmb H Neogenomics Inc Transaction History

Allianz Asset Management Gmb H

$69.7 Billion
Q3 2024

A detailed history of Allianz Asset Management Gmb H transactions in Neogenomics Inc stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 293,676 shares of NEO stock, worth $4.42 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

293,676

Previous 280,801 4.59%

Holding current value

$4.42 Million

Previous $3.89 Million 11.22%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$13.4 - $17.73 $172,525 - $228,273	12,875 Added 4.59%	293,676 $4.33 Million
Q2 2024 Aug 13, 2024	BUY	$13.01 - $15.77 $2,341 - $2,838	180 Added 0.06%	280,801 $3.89 Million
Q1 2024 May 13, 2024	SELL	$14.06 - $16.79 $53,048 - $63,348	-3,773 Reduced 1.33%	280,621 $4.41 Million
Q4 2023 Feb 12, 2024	BUY	$11.67 - $20.73 $637,987 - $1.13 Million	54,669 Added 23.8%	284,394 $4.6 Million
Q3 2023 Nov 13, 2023	SELL	$12.15 - $17.85 $60,519 - $88,910	-4,981 Reduced 2.12%	229,725 $2.83 Million
Q2 2023 Aug 11, 2023	BUY	$14.1 - $19.83 $253,715 - $356,821	17,994 Added 8.3%	234,706 $3.77 Million
Q1 2023 May 11, 2023	BUY	$9.09 - $19.45 $1.97 Million - $4.22 Million	216,712 New	216,712 $3.77 Million
Q2 2022 Aug 12, 2022	SELL	$7.06 - $13.97 $41,442 - $82,003	-5,870 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$12.15 - $35.28 $2.83 Million - $8.23 Million	-233,320 Reduced 97.55%	5,870 $71,000
Q4 2021 Feb 11, 2022	BUY	$30.49 - $48.49 $43,265 - $68,807	1,419 Added 0.6%	239,190 $8.16 Million
Q3 2021 Nov 10, 2021	BUY	$41.66 - $52.52 $6,124 - $7,720	147 Added 0.06%	237,771 $11.5 Million
Q2 2021 Aug 16, 2021	SELL	$36.62 - $51.69 $367,811 - $519,174	-10,044 Reduced 4.06%	237,624 $10.7 Million
Q1 2021 May 13, 2021	BUY	$41.56 - $59.88 $9.57 Million - $13.8 Million	230,341 Added 1329.38%	247,668 $11.9 Million
Q4 2020 Feb 16, 2021	SELL	$36.08 - $56.47 $1.05 Million - $1.65 Million	-29,141 Reduced 62.71%	17,327 $933,000
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $211,201 - $257,047	-6,350 Reduced 12.02%	46,468 $1.71 Million
Q2 2020 Aug 14, 2020	SELL	$24.21 - $31.02 $1.63 Million - $2.09 Million	-67,238 Reduced 56.01%	52,818 $1.64 Million
Q1 2020 May 14, 2020	SELL	$20.5 - $34.53 $1.35 Million - $2.27 Million	-65,873 Reduced 35.43%	120,056 $3.32 Million
Q4 2019 Feb 13, 2020	SELL	$18.96 - $29.84 $130,217 - $204,941	-6,868 Reduced 3.56%	185,929 $5.44 Million
Q3 2019 Nov 13, 2019	SELL	$19.12 - $26.24 $5.96 Million - $8.18 Million	-311,611 Reduced 61.78%	192,797 $3.69 Million
Q2 2019 Aug 08, 2019	SELL	$19.57 - $24.1 $1.57 Million - $1.93 Million	-79,972 Reduced 13.68%	504,408 $11.1 Million
Q1 2019 May 13, 2019	SELL	$12.14 - $20.46 $293,872 - $495,275	-24,207 Reduced 3.98%	584,380 $12 Million
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $204,174 - $336,052	18,165 Added 3.08%	608,587 $7.67 Million
Q3 2018 Nov 13, 2018	BUY	$12.5 - $15.38 $627,962 - $772,645	50,237 Added 9.3%	590,422 $9.06 Million
Q2 2018 Aug 13, 2018	SELL	$7.99 - $14.05 $28,364 - $49,877	-3,550 Reduced 0.65%	540,185 $7.08 Million
Q1 2018 May 14, 2018	SELL	$7.23 - $8.76 $91,228 - $110,533	-12,618 Reduced 2.27%	543,735 $4.44 Million
Q4 2017 Feb 13, 2018	SELL	$8.02 - $11.18 $991,183 - $1.38 Million	-123,589 Reduced 18.18%	556,353 $4.93 Million
Q3 2017 Nov 13, 2017	SELL	$9.11 - $11.26 $254,770 - $314,897	-27,966 Reduced 3.95%	679,942 $7.57 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-46,990 Reduced 6.22%	707,908 $6.34 Million
Q1 2017 Apr 17, 2019	SELL	N/A	-45,690 Reduced 5.71%	754,898 $5.96 Million
Q4 2016 Apr 17, 2019	SELL	N/A	-249,422 Reduced 23.75%	800,588 $6.86 Million
Q3 2016 Apr 17, 2019	BUY	N/A	1,050,010	1,050,010 $8.63 Million

Others Institutions Holding NEO

# of Institutions

293

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.89B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Neogenomics Inc Transaction History